Crinetics gets European approval for acromegaly drug PALSONIFY

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. UNP
9. GOOGL
10. DGX

Go back to Crinetics gets European approval for acromegaly drug PALSONIFY
(NASDAQ: CRNX) Delayed: 83.73 +0.08 (0.10%)
Previous Close $83.65    52 Week High $ 
Open $83.75    52 Week Low $ 
Day High $83.80    P/E N/A 
Day Low $83.68    EPS $ 
Volume 2,344,317